John R. Stuelpnagel - Dec 1, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Dec 1, 2021
Transactions value $
-$755,820
Form type
4
Date filed
12/3/2021, 04:51 PM
Previous filing
Nov 18, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$301K -2K -0.57% $150.51 350K Dec 1, 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale -$257K -1.7K -0.49% $151.10 348K Dec 1, 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale -$167K -1.1K -0.32% $151.79 347K Dec 1, 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale -$15.4K -100 -0.03% $154.02 347K Dec 1, 2021 Direct F1
transaction TXG Class A Common Stock Sale -$15.6K -100 -0.03% $155.55 347K Dec 1, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $150.00 to $150.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $151.00 to $151.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $151.53 to $152.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.